MARMIROLI, PAOLA LORENA
 Distribuzione geografica
Continente #
NA - Nord America 12.373
EU - Europa 5.808
AS - Asia 2.014
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 13
SA - Sud America 12
AF - Africa 9
Totale 20.246
Nazione #
US - Stati Uniti d'America 12.109
DE - Germania 1.185
CN - Cina 1.097
SE - Svezia 1.089
IT - Italia 906
IE - Irlanda 861
UA - Ucraina 654
VN - Vietnam 378
GB - Regno Unito 357
HK - Hong Kong 279
CA - Canada 257
AT - Austria 170
FI - Finlandia 149
RU - Federazione Russa 112
FR - Francia 105
DK - Danimarca 99
IN - India 71
TR - Turchia 47
NL - Olanda 41
JP - Giappone 40
SG - Singapore 37
KR - Corea 22
BE - Belgio 19
EU - Europa 16
PL - Polonia 12
IR - Iran 11
MY - Malesia 10
AU - Australia 9
BR - Brasile 9
ES - Italia 9
RO - Romania 9
BG - Bulgaria 7
TW - Taiwan 7
MX - Messico 6
CZ - Repubblica Ceca 5
GR - Grecia 5
EG - Egitto 4
NZ - Nuova Zelanda 4
RS - Serbia 4
IL - Israele 3
NO - Norvegia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
HR - Croazia 2
ID - Indonesia 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
EE - Estonia 1
IQ - Iraq 1
KZ - Kazakistan 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 20.246
Città #
Ann Arbor 2.915
Woodbridge 1.169
Houston 1.014
Chandler 864
Dublin 839
Fairfield 808
Frankfurt am Main 755
Wilmington 705
Jacksonville 693
Ashburn 532
Dearborn 518
Milan 369
New York 346
Princeton 328
Seattle 306
Hong Kong 279
Cambridge 271
Nanjing 212
Dong Ket 207
Vienna 168
Altamura 131
Beijing 113
Shanghai 112
Lachine 111
Lawrence 109
Guangzhou 87
Boardman 85
Nanchang 73
Grafing 67
Toronto 64
Shenyang 60
San Diego 57
Andover 47
Ottawa 46
Hebei 44
Jiaxing 43
Fremont 40
Jinan 40
Hangzhou 38
Falls Church 36
Helsinki 34
Los Angeles 32
Changsha 31
Sacramento 31
Carate Brianza 30
Tianjin 30
Detroit 29
Norwalk 28
Kunming 27
Pune 25
Edmonton 22
Huizen 22
Shangdi 22
Mountain View 21
Nürnberg 21
Zhengzhou 21
Hefei 20
Brussels 17
Ningbo 15
Rome 15
Taizhou 15
London 14
Auburn Hills 12
Chicago 12
Codroipo 12
Tokyo 12
Kiev 11
San Mateo 11
Kraków 9
Leawood 9
Mainz 9
Bergamo 8
Fuzhou 8
Paris 8
Tappahannock 8
Lissone 7
Piemonte 7
Redmond 7
Regensburg 7
Sesto San Giovanni 7
Changchun 6
Chengdu 6
Daejeon 6
Dallas 6
Monmouth Junction 6
Perugia 6
Philadelphia 6
Phoenix 6
University Park 6
Varese 6
Washington 6
Zanica 6
Cislago 5
Clarks Summit 5
Hyderabad 5
Kocaeli 5
Merate 5
Munich 5
Orange 5
Paderno Dugnano 5
Totale 15.499
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 362
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 280
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 257
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 256
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 254
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 246
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 221
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 218
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 194
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 190
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 186
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 177
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 177
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 177
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 169
Treatment of patients with neuropathy and anti-MAG IgM M-proteins. 169
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Pain in chemotherapy-induced peripheral neurotoxicity 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 164
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
Ultrastructural organization of lamina VI of the spinal cord of the cat. 160
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 160
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 159
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: Clinicopathological, neurophysiological, and immunological study 154
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats 154
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 152
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 151
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 151
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 149
Cryoglobulinaemic neuropathy: lack of progression in patients with good haematological control 149
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 147
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 146
Peripheral nervous system involvement in Niemann-Pick disease type 145
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. 145
Current view in platinum drug mechanisms of peripheral neurotoxicity 144
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 144
OCT2 transporter involvement in development of cisplatin toxicity 143
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 142
Neurotoxicity of oxaliplatin (I-OHP) in rats and influence of scheduling 142
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 142
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 142
Neurotrophin effect on the SH-SY5Y human neuroblastoma (HN) model of CDDP-induced neurotoxicity 142
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 141
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 141
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 139
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 138
Focus on the role of Glutamate in the pathology of the peripheral nervous system 138
Chemotherapy-induced peripheral neurotoxicity 135
Drugs for the treatment of peripheral neuropathies 135
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity? 135
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat 134
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 131
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 131
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy 131
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. 127
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 126
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 125
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 123
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 121
Sialidosis type I: pathological study in an adult. 121
Effects of repeated administration of low doses of cisplatin on the rat nervous system. 120
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity 120
Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity 120
Multimodal experimental approach to the study of human neurological diseases 118
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 118
Neurotrophins: effect on cisplatin-induced cytotoxicity and neurotoxicity in SH-SY5Y cells 117
Anti-sulfatide IgM antibodies in peripheral neuropathy 116
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 116
The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity 115
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 115
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 115
Tissue Distribution of Glutamate Carboxypeptidase II (GCPII) with a Focus on the Central and Peripheral Nervous System 114
Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies 113
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 113
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 112
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 112
Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? 111
The Glutamatergic Neurotransmission in the Central Nervous System 111
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 111
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 111
A role for hemopexin in oligodendrocyte differentiation and myelin formation 110
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 110
Totale 15.595
Categoria #
all - tutte 56.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019935 0 0 0 0 0 0 0 0 0 219 322 394
2019/20204.118 496 284 289 270 387 511 605 274 371 297 258 76
2020/20213.819 167 146 460 379 295 311 377 331 312 302 200 539
2021/20222.152 161 223 234 242 155 240 108 95 91 123 138 342
2022/20233.624 398 1.018 372 368 278 575 53 157 255 36 56 58
2023/20242.224 98 88 110 93 334 650 521 140 158 32 0 0
Totale 21.464